Related Experiment Video

Updated: May 22, 2026

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
11:50

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit

Published on: January 7, 2020

Early caffeine therapy and clinical outcomes in extremely preterm infants

R M Patel1, T Leong, D P Carlton

  • 1Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA. rmpatel@emory.edu

Journal of Perinatology : Official Journal of the California Perinatal Association
|April 28, 2012
PubMed

Insights

Early caffeine (EC) therapy in preterm infants significantly reduced bronchopulmonary dysplasia (BPD) or death and patent ductus arteriosus (PDA) treatment. EC also shortened mechanical ventilation duration, improving neonatal outcomes.

Area of Science:

  • Neonatal Medicine
  • Pharmacology
  • Respiratory Medicine

Background:

  • Bronchopulmonary dysplasia (BPD) and patent ductus arteriosus (PDA) are significant morbidities in preterm infants.
  • Caffeine citrate is a common respiratory stimulant used in neonatal intensive care units.

Purpose of the Study:

  • To evaluate the association between early caffeine (EC) therapy and improved neonatal outcomes.
  • To assess the impact of EC on BPD, PDA treatment, and ventilation duration.

Main Methods:

  • Retrospective cohort study of 140 neonates weighing ≤1250g at birth.
  • Comparison of infants receiving EC (initiation <3 days) versus late caffeine (LC) (initiation ≥3 days).
  • Logistic regression analysis was used to determine associations.

Main Results:

  • EC therapy was associated with a significant reduction in BPD or death (25% vs 53%, aOR 0.26).
  • Treatment for PDA was less frequent in the EC group (10% vs 36%, aOR 0.28).
  • The duration of mechanical ventilation was significantly shorter for infants receiving EC (6 days vs 22 days).

Conclusions:

  • Early caffeine therapy in preterm infants is linked to improved neonatal outcomes.
  • Further research is warranted to establish caffeine prophylaxis as a standard recommendation for preterm infants.
Abstract

More Related Videos

Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates05:58

Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates

Published on: September 6, 2017

Preterm EEG: A Multimodal Neurophysiological Protocol19:32

Preterm EEG: A Multimodal Neurophysiological Protocol

Published on: February 18, 2012

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Experimental Designs01:16

Experimental Designs

An experimental design is a systematic process that allows researchers to evaluate the relationship between dependent and independent variables. There are three widely used types of experimental design - pre-experimental design, true experimental design, and quasi-experimental design. In pre-experimental design, the researcher compares the data before and after some interventions or treatments. The true-experimental design has more than one purposefully created group, a commonly measured...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...